Insights

Growth signals Fulgent Genetics is actively expanding through acquisitions, including Bako Diagnostics and StrataDx, indicating a strategy to broaden laboratory capacity and service offerings in diagnostic testing which could open cross-sell opportunities for complementary genomics services, oncology, rare diseases, and reproductive health testing.

Financial watch Recent revenue fluctuations and guidance revisions for 2026, along with a current market cap around mid hundreds of millions, suggest a focus on expanding high-margin services, improving collection rates, and securing major client partnerships; this creates a window for value-based selling around efficiency gains and bundled test menus.

Service breadth A diversified testing menu spanning oncology, anatomic pathology, rare diseases, and reproductive health, supported by CLIA-certified and CAP-accredited operations, presents multiple entry points for upselling integrated genomic testing solutions and end-to-end diagnostic workflows.

Strategic partnerships Investments in complementary platforms such as Picture Genetics and Fulgent Oncology indicate a push toward specialized channels and vertical integrations; sales motions could target hospitals, clinics, and research institutes seeking cohesive genomic testing ecosystems.

Technology & data The tech stack including Apache Kafka, PostgreSQL, and cloud-ready tooling implies strong data integration and scale; this can be leveraged to propose advanced analytics, reporting, and data-driven decision support as value adds for payer leverage, clinical leadership, and streamlined workflows.

Similar companies to Fulgent Genetics

Fulgent Genetics Tech Stack

Fulgent Genetics uses 8 technology products and services including Paycom, Apache Kafka, Docker, and more. Explore Fulgent Genetics's tech stack below.

Media & News

Fulgent Genetics's Email Address Formats

Fulgent Genetics uses at least 4 email formats:
Fulgent Genetics Email FormatsExamplePercentage
FLast@fulgentgenetics.comJDoe@fulgentgenetics.com
77%
FirstLast@fulgentgenetics.comJohnDoe@fulgentgenetics.com
15%
First@fulgentgenetics.comJohn@fulgentgenetics.com
5%
FirstLas@fulgentgenetics.comJohnDoe@fulgentgenetics.com
3%

Frequently Asked Questions

What is Fulgent Genetics's phone number?

Minus sign iconPlus sign icon
You can contact Fulgent Genetics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Fulgent Genetics's stock symbol?

Minus sign iconPlus sign icon
Fulgent Genetics is a publicly traded company; the company's stock symbol is FLGT.

What is Fulgent Genetics's official website and social media links?

Minus sign iconPlus sign icon
Fulgent Genetics's official website is fulgentgenetics.com and has social profiles on LinkedIn.

How much revenue does Fulgent Genetics generate?

Minus sign iconPlus sign icon
As of October 2026, Fulgent Genetics's annual revenue is estimated to be $250M - $500M.

What is Fulgent Genetics's SIC code and NAICS code?

Minus sign iconPlus sign icon
Fulgent Genetics's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Fulgent Genetics have currently?

Minus sign iconPlus sign icon
As of October 2026, Fulgent Genetics has approximately 446 employees across 4 continents, including North America, Asia and Oceania. Key team members include Vice President Human Resources: E. T., President: J. X. and Managing Director: Y. M. P. F. C. Explore Fulgent Genetics's employee directory with LeadIQ.

What industry does Fulgent Genetics belong to?

Minus sign iconPlus sign icon
Fulgent Genetics operates in the Biotechnology Research industry.

What technology does Fulgent Genetics use?

Minus sign iconPlus sign icon
Fulgent Genetics's tech stack includes Paycom, Apache Kafka, Docker, Microsoft SharePoint, OneTrust, PostgreSQL, Microsoft Active Directory and Zendesk Chat.

What is Fulgent Genetics's email format?

Minus sign iconPlus sign icon
Fulgent Genetics's email format typically follows the pattern of FLast@fulgentgenetics.com. Find more Fulgent Genetics email formats with LeadIQ.

When was Fulgent Genetics founded?

Minus sign iconPlus sign icon
Fulgent Genetics was founded in 2011.
Fulgent Genetics logo

Fulgent Genetics

Biotechnology ResearchCalifornia, United States201-500 Employees

Fulgent Genetics is a biotechnology research company based in El Monte, California, with 201-500 employees, and it operates a CLIA-certified and CAP-accredited laboratory. Founded in 2011, the company functions as a full-service genomic testing provider built around a foundational technology platform, offering a diverse testing menu across oncology, anatomic pathology, infectious and rare diseases, and reproductive health. It maintains multiple product lines, including Fulgent Genetics, Fulgent Oncology, Fulgent BioPharma, Picture Genetics, and HelioLiver. The company is listed on NASDAQ under the ticker FLGT and has pursued recent strategic activities such as acquiring StrataDx and Bako Diagnostics in 2025, along with a 2025 partnership with Foundation Medicine. Reported revenue is in the range of $250 million to $500 million.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
FLGT
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
201-500

Section iconFunding & Financials

  • $250M - $500M

    Fulgent Genetics's revenue is estimated to be in the range of $250M - $500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.